Cost-effectiveness analysis of COVID-19 booster vaccination with BNT162b2 in Japan

Background The aim of this study was to evaluate the public health and economic impact of the COVID-19 booster vaccination with BNT162b2 in Japan during an Omicron-dominant period from early 2022.Research design and methods A combined cohort Markov decision tree model estimated the cost-effectivenes...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Mitsuhiro Nagano, Kazumasa Kamei, Hiroyuki Matsuda, Chihiro Takahashi, Jingyan Yang, Koji Wada, Naohiro Yonemoto
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Taylor & Francis Group 2024-12-01
Edice:	Expert Review of Vaccines
Témata:	COVID-19 SARS-CoV-2 vaccine booster cost-effectiveness Japan
On-line přístup:	https://www.tandfonline.com/doi/10.1080/14760584.2024.2323133
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!